Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Sage Therapeutics SAGE Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-324,692	Closed	-$13.8M	–	21
2021 Q4	$13.8M	Buy	324,692 +1,627	+0.5%	+$68.1K	4.17%	9
2021 Q3	$14.3M	Buy	323,065 +1,452	+0.5%	+$66.6K	4.1%	9
2021 Q2	$18.3M	Buy	321,613 +3,375	+1%	+$239K	5.12%	7
2021 Q1	$23.8M	Buy	318,238 +3,355	+1%	+$275K	7.13%	4
2020 Q4	$27.2M	Buy	314,883 +1,536	+0.5%	+$113K	12.22%	3
2020 Q3	$19.2M	Buy	313,347 +2,533	+0.8%	+$128K	10.41%	4
2020 Q2	$12.9M	Buy	310,814 +2,123	+0.7%	+$77.1K	7.61%	7
2020 Q1	$8.87M	Buy	308,691 +118,691	+62%	+$6.87M	9.75%	6
2019 Q4	$13.7M	Buy	+190,000	New	+$23.4M	11.97%	5

Other funds holding SAGE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's SAGE Position: Q1 2022 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold out of Sage Therapeutics (SAGE) in Q1 2022, closing a stake of 324,692 shares — an estimated $13.8M sold.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in SAGE in Q4 2019 and held it in 9 quarters. The position peaked at $27.2M in Q4 2020. 212 funds tracked by Wall St. Rank hold SAGE as of Q1 2022.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reported no remaining Sage Therapeutics position as of Q1 2022 after selling out during the quarter.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 324,692 Sage Therapeutics shares in Q1 2022, an estimated $13.8M.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Sage Therapeutics in Q4 2019 and held it in 9 quarters.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Sage Therapeutics position peaked at $27.2M in Q4 2020.
212 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2022.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q1 2022, filed 17 May 2024.